Consensus for the diagnosis, prognosis and treatment of canine mammary tumors-2013

Brazilian Journal of Veterinary Pathology

Volumn 7, Issue 2, 2014, Pages 38-69

  Cassali, Geovanni D ^a   Lavalle, Gleidice E ^a   Ferreira, Enio ^a   Estrela Lima, Alessandra ^b   de Nardi, Andrigo B ^c   Ghever, Cristina ^d   Sobral, Renata A ^e   Amorim, Renne L ^c   Oliveira, Luciana O ^f   Sueiro, Felipe A R ^g   Beserra, Hugo E O ^c   Bertagnolli, Angélica C ^h   Gamba, Conrado O ^a   Damasceno, Karine A ^a   Campos, Cecilia B ^a   Araujo, Marina R ^a   Campos, Liliane C ^a   Monteiro, Lidianne N ^a   Nunes, Fernanda C ^a   Horta, Rodrigo S ^a   Reis, Diego C ^a   Luvizotto, Maria Cecilia R ^c   Magalhães, Georgia M ⁱ   Raposo, Josiane B ^d   Ferreira, Ana M R ^j   Tanaka, Neide M ^k   Grandi, Fabrizio ^c   Ubukata, Rodrigo ^l   Batschinski, Karen ^l   Terra, Erika M ^c   Salvador, Rosana C L ^c   Jark, Paulo C ^c   Delecrodi, Juliana E R ^m   Nascimento, Nara A ^b   Silva, Danielle N ^b   Silva, Laís P ^b   Ferreira, Kelly Cristine R S ^f   Frehse, Michele S ⁿ   di Santis, Giovana W ⁿ   Silva, Elisângela O ⁿ   Guim, Tainã N ^o   Kerr, Beatriz ^p   Cintra, Priscila P ⁱ   Silva, Franciele B F ^j   Leite, Juliana S ^j   Mello, Marcela F V ^j   Ferreira, Maria de Lourdes G ^j   Fukumasu, Heidge ^q   Salgado, Breno S ^r   Torres, Rafael ^c   more..

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^e Onco Cane Clínica Veterinária Ltda   (Brazil)

^f HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^g Laboratório de Patologia e Biologia Molecular Veterinária   (Brazil)

^h Fepagro Saúde Animal Instituto de Pesquisas Veterinárias Desidério Finamor   (Brazil)

ⁱ UNIVERSIDADE DE FRANCA   (Brazil)

^j FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^k UNIVERSIDADE NORTE DO PARANÁ   (Brazil)

^l PROVET   (Brazil)

^m CenterVet Hospital Veterinário   (Brazil)

ⁿ STATE UNIVERSITY OF LONDRINA   (Brazil)

^o UNIPAMPA   (Brazil)

^p PAULISTA UNIVERSITY   (Brazil)

^q UNIVERSITY OF SÃO PAULO   (Brazil)

^r Universidade Jose do Rosario Vellano   (Brazil)

more..

Author keywords

Dogs; Mammary gland; Mammary neoplasias; Veterinary oncology

Indexed keywords

EID: 84905271041     PISSN: None     EISSN: 19830246     Source Type: Journal    
DOI: None     Document Type: Review

References (172)

1. ABREU E., KOIFMAN S. Fatores prognósticos no câncer da mama feminina. Rev. Bras. Cancerol., 2002, 48, 113-31.
2. AJCC, American Joint Committee on Cancer.
3. ANTUOFERMO E., MILLER MA., PIRINO S., XIE J., BADVE S., MOHAMMED SI. Spontaneous mammary intraepithelial lesions in dogs-a model of breast cancer. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 2247-56.
4. AULER P., BERTAGNOLLI AC., FERREIRA E., CAMPOS G., DIAS APM., CAMPOS CB., CAMPOS LC., CASSALI GD. Myeloid metaplasia in canine mixed mammary tumors: occurrence and characterization. Vet. Q., 2011, 31, 173-77.
5. BENTUBO HDL., SOBRAL RA., UBUKATA R., HONDA ST., XAVIER JG. Carcinoma inflamatório de mama em cadela-relato de caso. Rev. Clin. Vet., 2006, 65, 40-4.
6. BERTAGNOLLI AC., CASSALI GD., GENELHU MCLS., COSTA FA., OLIVEIRA JFC., GONÇALVES PBD. Immunohistochemical expression of p63 and Np63 in mixed tumors of canine mammary glands and its relation with p53 expression. Vet. Pathol., 2009, 46, 407-15.
7. BERTAGNOLLI, AC., FERREIRA, E., DIAS, EJ., CASSALI, GD. Canine mammary mixed tumors: immunohistochemical expressions of EGFR and HER-2. Aust. Vet. J., 2011, 89, 312-17.
8. BESERRA HEO., GRANDI F., IBANEZ FJ., ROCHA NS., PINHEIRO LGP. Sentinel lymph node identification: the importance of new methodologies and preclinical studies in dogs. Braz. J. Vet. Pathol., 2013, 6, 5.
9. BOSTOCK DE. Canine and feline mammary neoplasias. Br. Vet. J., 1986, 142, 506-15.
10. BRODEY RS., GOLDSCHMIDT MH., ROSZEL JR. Canine mammary gland neoplasias. J. Am. Anim. Hosp. Assoc., 1983, 19, 61-90.
11. BRUNETTI B., SARLI G., MARCATO PS., BENAZZI C. Histochemical and immunohistochemical characterization of canine mammary mucinous carcinoma. J. Comp. Pathol., 2003, 129, 131-36.
12. BRUNETTI B., SARLI G., PREZIOSI R., MONARI I., BENAZZI C. E-Cadherin and β-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors. Vet. Pathol., 2005, 42, 781-87.
13. CABANAS RM. An approach for the treatment of penile carcinoma. Cancer, 1997, 39, 456-66.
14. CAMPOS LC., LAVALLE GE., CARNEIRO RA., DUTRA AP., VIANA AAS., CASSALI GD. Carboplatina e inibidor de COX-2 no tratamento do carcinoma inflamatório de mama em cadela: relato de caso. Rev. Clin. Vet., 2011, 92, 72-76.
15. CAMPOS LC., LAVALLE GE., ESTRELA-LIMA A., MELGACO JC.̧ FARIA O., GUIMARAES JE., DUTRA AP., FERREIRA E., SOUSA LP., RABELO EML., COSTA AFDV., CASSALI GD. CA15.3, CEA, and LDH in dogs with malignant mammary tumors. J. Vet. Intern. Med., 2012, 26, 1383-88.
16. CARDOSO MJL., BARBOSA MVF., SILVA SRV., ROCHA NS., FABRIS VE. Inflammatory mammary carcinoma in bitch. Rev. Bras. Med. Vet., 2002, 24, 262-64.
17. CARTER MR., HORNICK JL., LESTER S., FLETCHER CD. Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am. J. Surg. Pathol., 2006, 30, 300-9.
18. CASSALI GD. Comparative mammary oncology: canine model. BMC Proc., 2013, 7, Suppl 2, K6.
19. CASSALI GD. Estudos morfológicos, imunohistoquímicos e citométrico de tumores mamários da cadela - aspectos comparativos com neoplasias da mama humana. (2000). 73 f. (Doutorado)-Ciência Animal, Universidade Federal de Minas Gerais, Belo Horizonte, 2000.
20. CASSALI GD. Patologias da glândula mamária. NASCIMENTO EF., LIMA RS. (Ed.). Patologia da reprodução dos animais domésticos. 3 Ed. Rio de Janeiro: Guanabara Koogan, 2002, 2, 131-33.
21. CASSALI GD., BERTAGNOLLI AC., FERREIRA E., DAMASCENO KA., GAMBA CO., CAMPOS CB. Canine mammary mixed tumors: a review. Vet. Med. International, 2012, 1-7.
22. CASSALI GD., BERTAGNOLLI AC., LAVALLE GE., TAVARES WLF., FERREIRA E., SILVA AE., CAMPOS CB. Perspectives for diagnosis, prognosis and treatment of mammary neoplasias in dogs. 34th World Small Animal Veterinary Congress-WSAVA 2009, São Paulo. Proceedings of the 34th World Small Animal Veterinary Congress-WSAVA, 2009.
23. CASSALI GD., GÄRTNER F., VIEIRA DA SILVA MJ., SCHMITT FC. Cytological diagnosis of a metastatic canine mammary tumor in pleural effusion. Arq. Bras. Med. Vet. Zootec., 1999, 51, 307-10.
24. CASSALI GD., GOBBI H., GARTNER F., SCHMITT FC. Secretory carcinoma of the canine mammary gland. Vet. Pathol., 1999b, 36, 601-03.
25. CASSALI GD., GOBBI H., MALM C., SCHMITT F. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumors: comparative features with human tumors. Cytopathol., 2007, 18, 191-96.
26. CASSALI GD., GOBBI H., MALMA C., OLIVEIRA SR., GHELLER VA. Protocol for the examination of cytologic specimens obtained by fine needle aspiration biopsy (FNAB) of canine breast tumors. Arq. Bras. Med. Vet. Zootec., 1998, 50, 475-78.
27. CASSALI GD., LAVALLE GE., DE NARDI AB., FERREIRA E., BERTAGNOLLI AC., ESTRELA-LIMA A., ALESSI AC., DALECK CR., SALGADO BS., FERNANDES CG., SOBRAL RA., AMORIM RL., GAMBA CO., DAMASCENO KA., AULER PA., MAGALHÃES GM., SILVA JO., RAPOSO JB., FERREIRA AMR., OLIVEIRA LO., MALM C., ZUCCARI DAPC., TANAKA NM., RIBEIRO LR., CAMPOS LC., SOUZA CM., LEITE JS., SOARES LMC., CAVALCANTI MF., FONTELES ZGC., SCHUCH ID., PANIAGO J., OLIVEIRA TS., TERRA EM., CASTANHEIRA TLL., FELIX AOC., CARVALHO GD., GUIM TN., GUIM TN., GARRIDO E., FERNANDES SC., MAIA FCL., DAGLI MLZ., ROCHA NS., FUKUMASU H., GRANDI F., MACHADO JP., SILVA SMMS., BEZERRIL JE., FREHSE MS., ALMEIDA ECP., CAMPOS CB. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Braz. J. Vet. Pathol., 2011, 4, 153-80.
28. CASSALI GD., GÄRTNER F., SCHMITT FC. Pleomorphic lobular carcinoma of the canine mammary gland: histopathologic and immunohistochemical features. Arq. Bras. Med. Vet. Zootec., 2002, 54.
29. CASSALI GD., SERAKIDES R., GÄRTNER F., SCHMITT FC. Invasive micropapillary carcinoma of the dog mammary gland. A case report. Arq. Bras. Med. Vet. Zootec., 2002, 24, 366-69.
30. CASTELLANO MC., IDIART JR. Carcinoma mamário inflamatório em la perra. Rev. Med. Vet., 1994, 76, 244-48.
31. CAVALCANTI MF. Fatores prognósticos na abordagem clínica e histopatológica dos carcinomas mamários de cadelas: estadiamento TNM e sistema de Nottingham. (2006). 106 f. (Mestrado)-Patologia, Universidade Federal de Minas Gerais, Belo Horizonte, 2006.
32. CAVALCANTI MF., CASSALI GD. Fatores prognósticos no diagnóstico clínico e histopatológico dos tumores de mama em cadelas-revisão. Rev. Clin. Vet., 2006, 11, 56-64.
33. CHANG SC., LIAO JW., WONG ML., LAI YS., LIU CI. Mammary carcinoma with sebaceous differentiation in a dog. Vet Pathol., 2007, 44, 525-27.
34. COSTA C., SOARES R., REIS-FILHO JS., LEITÃO D., AMENDOEIRA I., SCHMITT FC. Cyclo-oxigenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J. Clin. Pathol., 2002, 55, 429-34.
35. DABBS DJ., CARTER G., FUDGE M., PENG Y., SWALSKY P., FINKELSTEIN S. Molecular alterations in columnar cell lesions of the breast. Mod. Pathol., 2006, 19, 344-49.
36. DAGLI MLZ. The search for suitable prognostic markers for canine mammary tumors: A promising outlook. Vet. J., 2008, 177, 3-5.
37. DALECK CR., DE NARDI AB., RODASKI S. Oncologia em cães e gatos. 1 ed. São Paulo: Roca, 2009.
38. DALECK CR., FRANCESCHINI PH., ALESSI AC., SANTANA AE., MARTINS MIM. Aspectos clínico e cirúrgicos do tumor mamário canino. Ciênc. Rural, 1998, 28, 95-100.
39. DALECK CR., RODASKI S. Cirurgia oncológica. Eds. Oncologia em cães e gatos. São Paulo: Roca, 2009.
40. DAMASCENO KA., BERTAGNOLLI AC., ESTRELA-LIMA A., RABELO BS., CAMPOS, LC., RIBEIRO LGR., CASSALI GD. Versican expression in myoepithelial cells from carcinomas in canine mixed mammary tumors. Vet. J., 2014, 200, 146-51.
41. DAMASCENO KA., BERTAGNOLLI AC., ESTRELA-LIMA A., RIBEIRO LGR.; RABELO BS., CAMPOS CB., BARROS ALB., CASSALI GD. Versican expression in canine carcinomas in benign mixed tumors: is there an association with clinical pathological factors, invasion and overall survival? BMC Vet. Res., 2012, 8, 195.
42. DE NARDI AB., DALECK CR., LAUFER-AMORIM R., RODASKI S., PIEKARZ CH., MAGALHAES GM., CALAZANS SG., FERNANDES SC., CESAR JRF., CASTRO JHT., SILVA MCV., MOTTA FR. Correlação da cicloxigenase-2 com o prognóstico dos carcinomas mamários de cadelas. Acta Scient. Vet., 2007, 35, 619-27.
43. DE NARDI AB., RODASKI S., SOUSA RS., COSTA TA., MACEDO TR., RODIGHERI SM., RIOS A., PIEKARZ CH. Prevalência de neoplasias modalidade de tratamentos em cães, atendidos no Hospital Veterinário da Universidade Federal do Paraná. Arch. Vet. Sci., 2002, 7, 15-26.
44. DESTEXHE E., LESPAGNARD L., DEGEYTER M., HEYMAN R., COIGNOUL F. Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors. Vet. Pathol., 1993, 30, 146-54.
45. DI COSTANZO D., ROSEN PP., GAREEN I., FRANKLIN S., LESSER M. Prognosis in infiltrating lobular carcinoma. An analysis of classical and variant tumors. Am. J. Surg. Pathol., 1990, 14, 12-23.
46. DORÉ M., LANTHIER I., SIROIS J. Cyclooxygenase-2 expression in canine mammary tumors. Vet. Pathol., 2003, 40, 207-12.
47. DUTRA AP., AZEVEDO JUNIOR GM., SCHMITT FC., CASSALI GD. Assessment of cell proliferation and prognostic factors in canine mammary gland tumors. Arq. Bras. Med. Vet. Zootec., 2008, 60, 1403-12.
48. DUTRA AP., GRANJA NVM., SCHMITT FC., CASSALI GD. C-erbB-2 expression and nuclear pleomorphism in canine mammary tumors. Braz. J. Med. Biol. Res., 2004, 37, 1673-81.
49. EL-GOHARY YM., METWALLY G., SAAD RS., ROBINSON MJ., MESKO T., POPPITI RJ. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas. Am. J. Clin. Pathol., 2008, 129, 578-86.
50. ELSTON CW., ELLIS IO. Assessment of histological grade. ELSTON CW., ELLIS IO. Eds. Systemic Pathology. The breast. London: Churchill Livingstone, 1998, 365-84.
51. ELSTON CW., ELLIS IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathol., 1991, 19, 403-10.
52. ERDELYI I., VAN ASTEN AJ., VAN DIJK JE., NEDERBRAGT H. Expression of versican in relation to chondrogenesis-related extracellular matrix components in canine mammary tumors. Histochem. Cell Biol., 2005, 124, 139-49.
53. ESPINOSA DE LOS MONTEROS A., HELLMÉN E., RAMÍREZ GA., HERRÁEZ P., RODRÍGUEZ F., ORDÁS J., MILLÁN Y., LARA A., MARTÍN DE LAS MULAS J. Lipid-rich carcinomas of the mammary gland in seven dogs: clinicopathologic and immunohistochemical features. Vet. Pathol., 2003, 40, 718-23.
54. ESPINOSA DE LOS MONTEROS A., MILLÁN MY., ORDÁS J., CARRASCO L., REYMUNDO C., MARTÍN DE LAS MULAS J. Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium. Vet. Pathol., 2002, 39, 247-56.
55. ESPINOSA DE LOS MONTEROS A., MILLÁN MY., RAMÍREZ GA., ORDÁS J., REYMUNDOC., MARTÍN DE LAS MULAS J. Expression of maspin in mammary gland tumors of the dog. Vet. Pathol., 2005, 42, 250-57.
56. ESTRELA-LIMA A., ARAUJO MSS., COSTA-NETO JM., TEIXEIRA-CARVALHO A., BARROUIN-MELO SM., CARDOSO SV., MARTINS-FILHO OA., SERAKIDES R., CASSALI GD. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer, 2010, 10, 1-14.
57. EVANS HL., AYALA AG., ROMSDAHL MM. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer, 1977, 40, 818-31.
58. FERGUSON HR., Canine mammary gland tumors. Vet. Clin. North. Am. Small. Anim. Pract., 1985, 15, 501-11.
59. FERREIRA E., GOBBI H., SARAIVA BS., CASSALI GD. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs. Vet. Pathol., 2012, 49, 322-9.
60. FERREIRA E. Análise histomorfológica, imuno-histoquímica e de hibridização cromogênica in situ em lesões mamárias epiteliais ductais não neoplásicas de cadelas. (2010). (Doutorado)-Patologia, Universidade Federal de Minas Gerais, Belo Horizonte, 2010.
61. FERREIRA E., BERTAGNOLLI AC., CAVALCANTI MF., SCHMITT FC., CASSALI GD. The relationship between tumor size and expression of prognostic markers in benign and malignant canine mammary tumors. Vet. Comp. Oncol., 2009, 193, 1-6.
62. FERREIRA E., BREGUNCI GC., SCHMITT FC., CASSALI GD. Protocol for the anatomopathological examination of canine mammary tumors. Arq. Bras. Med. Vet. Zootec., 2003, 55, 105-09.
63. FERREIRA E., GOBBI H., SARAIVA B., CASSALI G. Columnar cell lesions of the canine mammary gland: pathological features and immunophenotypic analysis. BMC Cancer, 2010, 10, 1-7.
64. FONSECA CS., DALECK CR. Neoplasias mamárias em cadelas: influência hormonal e efeitos da ovario-histerectomia como terapia adjuvante. Ciênc. Rural, 2000, 30, 731-35.
65. GAMA A., ALVES A., GARTNER F., SCHMITT F. P63: a novel myoepithelial cell marker in canine mammary tissues. Vet. Pathol., 2003, 40, 412-20.
66. GAMA A., ALVES A., SCHMITT FC. Clinicopathologic features of mammary invasive micropapillary carcinoma (IMC) in dogs. Vet. Pathol., 2008a, 45, 600-01.
67. GAMA A., PAREDES J., GÄRTNER F., ALVES A., SCHMITT F. Expression of E-cadherin, P-cadherin and β-catenin in canine malignant mammary tumors in relation to clinicopathological parameters, proliferation and survival. Vet. J., 2008b, 177, 45-53.
68. GAMBA CO., DIAS EJ., RIBEIRO LGR., CAMPOS LC., ESTRELA-LIMA A., FERREIRA E., CASSALI GD. Histopathological and immunohistochemical assessment of invasive micropapillary mammary carcinoma in dogs: A retrospective study. Vet. J., 2013, 196, 241-6.
69. GERALDES M., GÄRTNER F., SCHMITT F. An immunohistochemical study of hormonal receptors and cell proliferation in normal canine mammary glands and spontaneous mammary tumors. Vet. Rec., 2000, 146, 403-06.
70. GILBERTSON SR., KURZMAN ID., ZACHRAU RE., HURVITZ AI., BLACK MM. Canine mammary epithelial neoplasias: biologic implications of morphologic characteristics assessed in 232 dogs. Vet. Pathol., 1983, 20, 127-42.
71. GILSON SD. Clinical management of the regional lymph node. Vet. Clin. North Am. Small Anim. Pract., 1995, 25, 149-67.
72. GOLDHIRSCH A., GLICK JH., GELBER RD., COATES AS., THURLIMANN B., SENN HJ., MEMBER P. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann. Oncol., 2005, 16, 1569-83.
73. GOMES C., VOLL J., FERREIRA KCRS., FERREIRA RR., OLIVEIRA LO., CONTESINI EA., OLIVEIRA RT. Carcinoma inflamatório mamário canino. Acta Scien. Vet., 2006, 34, 171-74.
74. GOYAL A., NEWCOMBE RG., CHHABRA A., MANSEL RE. ALMANAC Trialists Group. Factors affecting failed localization and false-negative rates of sentinel node biopsy in breast cancer-results of the ALMANAC validation phase. Breast Cancer Res. Treat., 2006, 99, 203-8.
75. GRANDI F., COLODEL MM., MONTEIRO LN., LEÃO JRVP., ROCHA NS. Extramedullary hematopoiesis in a case of benign mixed mammary tumor: cytological and histopathological assessment. BMC Vet. Res., 2010, 6, 45.
76. HAMMOND MEH., HAYES DF., DOWSETT MD., ALLRED C., HAGERTY KL., BADVE S., FITZGIBBONS PL., FRANCIS G., GOLDSTEIN NS., HAYES M., HICKS DG., LESTER S., LOVE R., MANGU PB., MCSHANE L., MILLER K., OSBORNE CK, PAIK S., PERLMUTTER J., RHODES A., SASANO H., SCHWARTZ JN., SWEEP FCG., TAUBE S., TORLAKOVIC EE., VALENSTEIN P., VIALE G., VISSCHER D., WHEELER T., WILLIAMS RB., WITTLIFF JL., WOLFF AC. American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol., 2010, 28, 2784-95.
77. HANBY AM., HUGHES TA. In situ and invasive lobular neoplasia of the breast. Histopathol., 2008, 52, 58-66.
78. HELLER DA., CLIFFORD CA., GOLDSCHMIDT MH., HOLT DE., SHOFER FS., SMITH A., SORENMO KU. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma. Vet. Pathol., 2005, 46, 776-780.
79. HELLMÉN E., BERGSTRÖM R., HOLMBERG L., SPÅNGBERG IB., HANSSON K., LINDGREN A. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases. Vet. Pathol., 1993, 30, 20-27.
80. HORTA RS., LAVALLE GE., CUNHA RMC., MOURA LL., ARAÚJO RB., CASSALI GD. Influence of surgical technique on overall survival, disease free interval and new lesion development interval in dogs with mammary tumors. Adv. Breast. Cancer. Res., 2014, 3, 38-46.
81. JAIYESIMI IA., BUZDAR AU., HORTOBAGYI G. Inflammatory breast cancer: a review. J. Clin. Oncol., 1992, 10, 1014-24.
82. KAMSTOCK DA., EHRHART EJ., GETZY DM., BACON NJ., RASSNICK KM., MOROFF SD., LIU SM., STRAW RC., MCKNIGHT CA., AMORIM RL., BIENZLE D., CASSALI GD., CULLEN JM., DENNIS MM., ESPLIN DG., FOSTER RA., GOLDSCHMIDT MH., GRUBER AD., HELLMÉN E., HOWERTH EW., LABELLE P., LENZ SD., LIPSCOMB TP., LOCKE E., MCGILL LD., MILLER MA., MOUSER PJ., O'TOOLE D., POOL RR., POWERS BE., RAMOS-VARA JA., ROCCABIANCA P., ROSS AD., SAILASUTA A., SARLI G., SCASE JT., SCHULMAN FY., SHOIEB AM., SINGH K., SLEDGE D., SMEDLEY RC., SMITH KC., SPANGLER WL., STEFICEK B., STROMBERG PC., VALLI VE., YAGER J., KIUPEL M. Recommended guidelines for submission, trimming, margin evaluation, and reporting of tumor biopsy specimens in veterinary surgical pathology. Vet. Pathol., 2011, 48, 19-31.
83. KANDEMIR NO., BARUT F., BEKTAS S., OZDAMAR SO. Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas? Pathol. Oncol. Res., 2011, 18, 253-62.
84. KARAYANNOPOULOU M., KALDRYMIDOU E., CONSTANTINIDIS TC., DESSIRIS A. Histological grading and prognosis in dogs with mammary carcinomas: application of a human grading method. J. Comp. Pathol., 2005, 20, 1-7.
85. KARAYANNOPOULOU M., KALDRYMIDOU E., CONSTANTINIDIS TC., DESSIRIS A. Adjuvant post-operative chemotherapy in bitches with mammary cancer. J. Vet. Med. A. Physol. Pathol. Clin. Med., 2001, 48, 85-96.
86. KESHGEGIAN AA., CNAAN A. Proliferation markers in breast carcinoma: mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and KI-67. Am. J. Clin. Pathol., 1995, 104, 42-49.
87. KURZMAN ID., GILBERTSON SR. Prognostic factors in canine mammary tumors. Semin. Vet. Med. Surg. (Small Animal), 1986, 1, 25-32.
88. KUSEWITT DF., HAHN FF., MUGGENBURG BA. Ultrastructure of a spindle cell carcinoma in the mammary gland of a dog. Vet. Pathol., 1992, 29, 179-81.
89. LAGADIC M., ESTRADA M., CAMADRO JP., DURAND P., GOEBEL J. Tumeurs mammaries de la chienne: critères du prognostic histologique et intéret d'un grading. Rec. Méd. Vét., 1990, 166, 1035-42.
90. LANGENBACH A., MCMANUS P., HENDRICK M., SHOFER FS., SORENMO KU. Sensitivity and specificity of methods of assessing the regional lymph nodes for evidence of metastasis in dogs and cats with solid tumors. J. Am. Vet. Med. Assoc., 2001, 218, 1424-8.
91. LAUFER-AMORIM R., SOUZA CHM., BANDARRA EP., SANCHES OC., PIZA ET. Immunohistochemical study of estrogen and progesterone receptors and cell proliferative index in canine inflammatory mammary carcinoma: 9 cases. Braz. J. Vet. Pathol., 2008, 1, 16-20.
92. LAVALLE GE., BERTAGNOLLI AC., TAVARES WLF., CASSALI GD. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival. Vet. Pathol., 2009, 46, 1275-80.
93. LAVALLE, GE., CAMPOS, CB., BERTAGNOLLI, AC., CASSALI, GD. Canine malignant mammary gland neoplasias with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors. In Vivo, 2012, 26, 375-9.
94. LIPSCOMB TP. Prognostic studies of mammary and other neoplasia in veterinary medicine: a new paradigm. Vet. J., 2012, 193, 1.
95. LOSCO PE. Local and peripheral eosinophilia in a dog with anaplastic mammary carcinoma. Vet. Pathol., 1986, 23, 536-38.
96. LUNA-MORÉ S., GONZALEZ B., ACEDO C., RODRIGO I., LUNA C. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol. Res. Pract., 1994, 190, 668-64.
97. MACEWEN EG., HARVEY HJ., PATNAIK AK., JAY H., PATNAIK AK., MOONEY S., HAYES A., KURZMAN I., HARDY WDJ. Evaluation of effects of levamisole and surgery on canine mammary cancer. J. Biol. Response Mod., 1985, 4, 418-26.
98. MACEWEN EG., PATNAIK AK., HARVEY HJ., PANKO WB. Estrogen receptors in canine mammary tumors. Cancer Res., 1982, 42, 2255-9.
99. MARCONATO L., LORENZO RM., ABRAMO F., RATTO A., ZINI E. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumors in dogs. Vet. Comp. Oncol., 2008, 6, 90-101.
100. MARINHO VFZ., METZE K., SANCHES FSF., ROCHA GFS., GOBBI H. Marcadores moleculares em câncer de mama preditivos de metástases axilares. Rev. Assoc. Med. Bras., 2008, 53, 203-7.
101. MARTIN PM., COTARD M., MIALOT JP., ANDRÉ F., RAYNAUD JP. Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemother. Pharmacol., 1984, 12, 13-7.
102. MARTINS DC., PLIEGO CM., FERREIRA MLG., FERREIRA AMR. Utilização de marcadores prognósticos no estudo da proliferação celular em adenocarcinomas mamários. Ciênc. Anim. Bras., 2008, 9, 125-7.
103. MATOS AJF., FAUSTINO AMR., LOPES C., RUTTEMAN GR., GÄRTNER F. Detection of lymph node micrometastases in malignant mammary tumors in dogs by cytokeratin immunostaining. Vet. Rec., 2006, 158, 626-30.
104. MENDES TC., GUIM TN., DIAS MCF., BONEL-RAPOSO J., FERNANDES CG. Comparação entre os sistemas histomorfológico e de graduação histológica para classificação prognóstica de tumores mamários em cadelas. Acta Scient. Vet., 2007, 35, 339-45.
105. MISDORP W. Tumors of the mammary gland. DJ M. Eds. Tumors in domestic animals. Ames: Blackwell, 2002, 575-606.
106. MISDORP W., COTCHIN E., HAMPE JF., JABARA AG., VON SANDERSLEBEN J. Canine malignant mammary tumors III. Special types of carcinomas, malignant mixed tumors. Vet. Pathol., 1973, 10, 241-56.
107. MISDORP W., ELSE RW., HELLMÉN E., LIPSCOMB E. Definitions and explanatory notes. WHO histological classification of mammary tumors of the dog and cat. washington: Armed Forces Institute of Pathology, 1999, 18-27.
108. MORRISON WB. Canine and feline mammary tumors. Eds. Cancer in dogs and cats: medical and surgical management. 1st ed. Philadelphia: Lippincott, Willians & Wilkins, 1998, 591-8.
109. MOUSER P., MILLER MA., ANTUOFERMO E., BADVE SS., MOHAMMED SI. Prevalence and classification of spontaneous mammary intraepithelial lesions in dogs without clinical mammary disease. Vet. Pathol., 2010, 47, 265-74.
110. MURAKAMI A., KAWACHI K., SASAKI T., ISHIKAWA T., NAGASHIMA YOJI., NOZAWA A. Sebaceous carcinoma of the breast. Pathol. Int., 2009, 59, 188-92.
111. NIETO A., PÉREZ-ALENZA MD., DEL CASTILLO N., TABANERA E., CASTAÑO M., PEÑA L. BRCA-1 expression in canine mammary dysplasias and tumors: relationship with prognostic variables. J. Comp. Pathol., 2003, 128, 260-8.
112. OGILVE GK., MOORE AS. Mammary neoplasia. Eds. Managing the veterinary cancer patient; a practice manual. New Jersey: Veterinary learning systems co., 1996, 431-3.
113. OWEN LN. TNM Classification of tumors in domestic animals. Ed. Geneva: World Health Organization, 1980.
114. PAL SK., LAU SK., KRUPER L., NWOYE U., GARBEROGLIO C., GUPTA RK., PAZ B., VORA L., GUZMAN E., ARTINYAN A., SOMLO G. Papillary carcinoma of the breast: an overview. Breast Cancer Res. Treat., 2010, 122, 637-45.
115. PATSIKAS MN., DESSIRIS A. The lymph drainage of the neoplastic mammary glands in the bitch: a lymphographic study. Anat. Hist. Embry., 2006, 35, 228-34.
116. PEÑA LL., NIETO AI., PEREZ-ALENZA D., CUESTA P., CASTAÑO M. Immunohistochemical Detection of Ki-67 and PCNA in canine mammary tumors: Relationship to clinical and pathologic variables. J. Vet. Diagn. Invest., 1998, 10, 237-46.
117. PEÑA L., PÉREZ-ALENZA MD., RODRIGUES-BERTOS A., NIETO A. Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases. Breast. Canc. Res. Treat., 2003, 78, 141-8.
118. PENG L., SUN Q., LIANG Z., ZHOU Y., MAO F., GUAN J. Pure mucinous carcinoma of the breast: a clinicopathologic analysis with 56 patients. Chinese Med. Sci. J., 2010, 25, 115-8.
119. PEREZ-ALENZA MD., TABANERA E., PEÑA L. Inflammatory mammary carcinoma in dogs: 33 cases (1995-1999). J. Am. Vet. Med. Assoc., 2001, 219, 1110-4.
120. PÉREZ-MARTINEZ C., GARCIA-IGLESIAS MJ., DURÁN NAVARRETE AJ., ESPINOSA-ALVAREZ J., GARCÍA FERNÁNDEZ RA., LORENZANA-ROBLES N., FERNÁNDEZ-PÉREZ S., GARCÍA-MARÍN JF. Histopathological and immunohistochemical characteristics of two canine lipid-rich mammary carcinomas. J. Vet. Med. A. Physiol. Pathol. Clin. Med., 2005, 52, 61-6.
121. PEROU CM., SORLIE T., EISEN MB., VAN DE RIJN M., JEFFREY SS., REES CA., POLLACK JR., ROSS DT., JOHNSEN H., AKSLEN LA., FLUGE O., PERGAMENSCHIKOV A., WILLIAMS C., ZHU SX., LONNING PE., BORRESEN-DALE AL., BROWN PO., BOTSTEIN D. Molecular portraits of human breast tumors. Nature, 2000, 406, 747-52.
122. PINHEIRO LG., OLIVEIRA FILHO RS., VASQUES PH., FILGUEIRA PH., ARAGÃO DH., BARBOSA PM., BESERRA HE., CAVALCANTE RV. Hemosiderin: a new marker for sentinel lymph node identification. Acta Cir. Bras., 2009, 24, 432-6.
123. PINHEIRO LGP., MORAES MO., SOARES AH., LOPES AJT., NAGUÉRE MASP., GONDIM FAL., BRANDÃO CB., NASCIMENTO DCH., SOARES JPH., MENESES E SILVA JM. Estudo Experimental de linfonodo sentinela na mama da cadela com azul patente e tecnécio Tc99. Acta Cir. Bras., 2003, 18, 545-52.
124. POLTON, G. Mammary tumors in dogs. Irish Vet. J., 2009, 62, 1, 50-6.
125. QUEIROGA F., LOPES C. Tumores mamários caninos, pesquisa de novos fatores prognósticos. Rev. Port. Ciênc. Vet., 2002, 97, 119-27.
126. REIS-FILHO JS., LAKHANI SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res., 2003, 5, 313-19.
127. RESSEL L., MILLANTA F., POLI A. Canine invasive lobular carcinoma of mammary gland: morphological and immunohistochemical characterization of three cases. J. Comp. Pathol., 2010, 1-5.
128. RIBEIRO GM. Carcinoma em tumor misto da mama da cadela: avaliação de aspectos morfológicos e perfil imunofenotípico. 73f. (Mestrado) - Patologia, Universidade Federal de Minas Gerais, Belo Horizonte, 2010.
129. RIBEIRO LGR., DAMASCENO KA., COSTA-NETO JM., DASSIS MJMH., SILVA NS., AGUIAR PHP., CASSALI GD., ESTRELA-LIMA A. Expressão da COX-2 nos carcinomas maários de cadelas. Vet. Foco, 2009, 6, 134-9.
130. RIBEIRO, GM., ROCHA, RM., BERTAGNOLLI, AC., CASSALI, GD. Morphological aspects and immunophenotypic profiles of mammary carcinomas in benign-mixed tumors of female dogs. Vet. Med. International, 2012, 7.
131. RIVA GT., HART BL., FARVER TB., OBERBAUER AM., MESSAM LL., WILLITS N., HART LA. Neutering dogs: effects on joint disorders and cancers in Golden Retrievers. Plos One, 2013, 8, 10.
132. RODASKI S., DE NARDI AB. Fármacos naturais.Eds. Quimioterapia Antineoplásica em Cães e Gatos. São Paulo: Medvet., 2008, 96-109.
133. RODASKI S., DE NARDI AB., PIEKARZ CH. Quimioterapia antineoplásica. Eds. Oncologia em cães e gatos. São Paulo: Roca, 2009.
134. ROSEN PP. Eds. Rosen's Breast Pathology. Mucinous carcinoma. 3 Ed. Lippincott Williams & Wilkins, 2009: 515-35.
135. ROSEN PP. Eds. Rosen's Breast Pathology. Papillary carcinoma. 3 Ed. Lippincott Williams & Wilkins, 2009: 423-48.
136. ROSEN PP. Eds. Rosen's Breast Pathology. Secretory carcinoma. 3 Ed. Lippincott Williams & Wilkins, 2009: 563.
137. ROSEN PP., OBERMAN HA. Eds. Tumors of the mammary gland. atlas of tumor pathology. Fasc. 7. Invasive lobular carcinoma. Armed Forces Institute of Pathology, Washington DC. 1993:168-75.
138. SALGADO BS., MONTEIRO LN., COLODEL MM., FIGUEIROA FC., SOARES LM., NONOGAKI S., ROCHA RM., ROCHA NS. Clinical, cytologic, and histologic features of a mammary micropapillary carcinoma in a dog. Vet. Clin. Pathol., 2013, 42, 382-5.
139. SCHNEIDER R., DORN CR., TAYLOR DON. Factors influencing canine mammary tumor development and postsurgical survival. J. Natl. Cancer Inst., 1969, 43, 1249-1.
140. SCHOPPMANN SF., BIRNER P., STUDER P., BREITENEDER-GELEFF S. Lymphatic microvessel densitiy and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res., 2001, 21, 2351-5.
141. SEIXAS F., PALMEIRA C., PIRES MA., LOPES C. Mammary invasive micropapillary carcinoma in cats: clinicopathologic features and nuclear DNA content. Vet. Pathol., 2007, 44, 842-848.
142. SILVA AE., SERAKIDES R., CASSALI GD. Carcinogênese hormonal e neoplasias hormônio-dependentes. Ciênc. Rural, 2004, 34, 625-33.
143. SILVER SA., TAVASSOLI AF. Mammary ductal carcinoma in situ with microinvasion. Am. Cancer Soc., 1998, 82, 2382-90.
144. SINGLETARY SE., PATEL-PAREKH L., BLAND KI. Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base. Ann. Surg., 2005, 242, 281-9.
145. SOBIN L., WITTEKIND C. TNM classification of malignant tumors. Eds. New York: Wiley-Liss, 1997.
146. SORENMO K. Canine mammary gland tumors. Vet. Clin. North Am. Small Anim. Pract., 2003, 33, 573-96.
147. SORENMO KU., DEANNA RW., GOLDSMIDT RH. Tumors of the mammary gland. WITHROW SJ., VAIL DM. Withrow & MacEwen's small animal clinical oncology. 5° Ed. Philadelphia: W. B. Saunders Company. 2013, 553-571.
148. SORENMO KU., RASOTTO R., ZAPPULLI V., GOLDSCHIMIDT MH. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasias. Vet. Pathol., 2011, 48-85.
149. SORLIE T., TIBSHIRANI R., PARKER J., HASTIE T., MARRON JS., NOBEL A., DENG S., JOHNSEN H., PESICH R., GEISLER S., DEMETER J., PEROU CM., LONNING PE., BROWN PO., DALE ALB., BOTSTEIN D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. Unit. States Am., 2003, 100, 8418-23.
150. SOUZA CHM., TOLEDO-PIZA E., AMORIN R., BARBOZA A., TOBIAS KM. Inflammatory mammary carcinoma in 12 dogs: Clinical features, cyclooxygenase-2 expression, and response to piroxicam treatment. Can. Vet. J., 2009, 50, 506-10.
151. SOUZA FW., BRUN MV., NARDI AB., HUPPES RR., RAPOSO TMM., KASPER PN., OLIVEIRA MT., GUEDES RL. Linfadenectomia laparoscópica em cadela com neoplasia mamária. Ciênc. Rural, 2013, 43, 750-3.
152. STERNLICHT MD., KEDESHIAN P., SHAO ZM., SAFARIANS S., BARSKY SH. The human myoepithelial cell is a natural tumor suppressor. Clin. Cancer Res., 1997, 3, 1949-58.
153. STRATMANN N., FAILING K., RICHTER A., WEHREND A. Mammary tumor recurrence in bitches after regional mastectomy. Vet. Surg., 2008, 37, 82-86.
154. SUSANECK SJ., ALLEN TA., HOOPES J., WITHROW SJ., MACY DW. Inflammatory mammary carcinoma in the dog. J. Am. An. Hosp. Assoc., 1983, 19, 971-6.
155. SUZUKI F., SAITO A., ISHI K., OKAZAKI T., KINA K., KOYATSU J., SUGIYAMA K. Secretory carcinoma of the breast: an immunohistochemical and ultrastructural study. Med. Electron. Microsc., 1999, 32, 50-6.
156. TAVARES WLF., FIGUEIREDO MS., SOUZA AG., BERTAGNOLLI AC., LAVALLE GE., CAVALCANTI G., CASSALI GD. Evaluation of dose and side effects of tamoxifen in female dogs. V ONCOVET. Vet. Comp. Oncol., 2009, 7, 93-4.
157. TAVASSOLI FA., DEVILEE P. Pathology and genetics of tumors of the breast and female genital organs. 1 ed. Tumors of the breast. Lyon: IARC Press. 2003:09-112.
158. TERZIAN ACB., ZUCCARI DAPC., PEREIRA RS., PAVAM MV., COELHO J. Avaliação da caspase 3 e ki 67 como marcadores prognósticos nas neoplasias mamárias em cadelas. Braz. J. Vet. Res. Anim. Sci., 2007, 44, 96-102.
159. TOKUDOME N., SAKAMOTO G., SAKAI T., SARUMARU S., OKUYAMA N., HORI F., HORII R., AKIYAMA F., TANABE M., SAITO K., TAKAHASHI K., KASUMI F. A Case of carcinosarcoma of the breast. Breast Cancer, 2005, 12, 149-53.
160. UENG S., MEZZETTI T., TAVASSOLI FA. Papillary neoplasias of the breast: a review. Arch. Pathol. Lab. Med., 2009, 133, 893-907.
161. UVA P., AURISICCHIO L., WATTERS J., LOBODA A., KULKARNI A., CASTLE J., PALOMBO F., VITI V., MESITI G., ZAPPULLI V., MARCONATO L., ABRAMO F., CILIBERTO G., LAHM A., MONICA N., RINALDIS E. Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics, 2009, 10, 1-20.
162. VELDHOEN N., WATTERSON J., BRASH M., MILNER J. Identification of tumor-associated and germ line p53mutations in canine mammary cancer. Brit. J. Cancer, 1999, 81, 409-415.
163. WAHED A., CONNELLY J., REESE T. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Ann. Diagn. Pathol., 2002, 6, 349-51.
164. WELLS S., BENNETT A., WALSH P., PEAUROI J. Clinical usefulness of intradermal fluorescein and patent blue violet dyes for sentinel lymph node identification in dogs. Vet. Comp. Oncol., 4, 114-22, 2006.
165. WERNER PR., WERNER J. Avaliação histopatológica. DALECK CR. Ed. Oncologia em cães e gatos. São Paulo: Roca, 2009, 121-34.
166. WILLIAMS LE., PACKER RA. Association between lymph node size and metastasis in dogs with malignant melanoma: 100 cases (1987-2001). J. Am. Vet. Med. Assoc., 2003, 222, 1234-1236.
167. WOLFF AC., HAMMOND MEH., SCHWARTZ JN., HAGERTY KL., ALLRED DC., COTE RJ., DOWSETT M., FITZGIBBONS PL., HANNA WM., LANGER A., MCSHANE LM., PAIK S., PEGRAM MD., PEREZ EA., PRESS MF., RHODES A., STURGEON CATHARINE., TAUBE SE., TUBBS R., VANCE GH., VIJVER MV., WHEELER TM., HAYES DF. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J. Clin. Oncol., 2007, 25, 118-45.
168. YAMAGAMI T., KOBAYASHI T., TAKAHASHI K., SUGIYAMA M. Prognosis for canine malignant mammary tumors based on TNM and histologic classification. J. Vet. Med. Sci., 1996, 58, 1079-83.
169. YAZIJI H., GOWN AM., SNEIGE N. Detection of stromal invasion in breast cancer: the myoepithelial markers. Adv. Anat. Pathol., 2000, 7, 100-109.
170. ZUCCARI DAPC., PAVAM MV., TERZIAN ACB., PEREIRA RS., RUIZ CM., ANDRADE JCA. Immunohistochemical Evaluation of e-cadherin, Ki-67 and PCNA in Canine Mammary Neoplasia: Correlation of Prognostic Factors and Clinical Outcome. Pesq. Vet. Bras., 2008, 28, 207-15.
171. ZUCCARI DAPC., SANTANA AE., CURY PM., CORDEIRO JA., ZANCHETTA NETTO D. Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Vet. Clin. Pathol., 2004, 33, 23-28.
172. ZUCCARI DAPC., SANTANA AE., ROCHA NS. Correlação entre a citologia aspirativa por agulha fina e a histologia no diagnóstico de tumores mamários de cadelas. Braz. J. Vet. Res. Anim. Sci., 2001, 38, 38-41.